Related Experiment Video
Updated: Aug 13, 2026

Application of Acupotomy in a Knee Osteoarthritis Model in Rabbit
Published on: October 20, 2023
Ninth Asia Pacific League of Associations for Rheumatology (APLAR) Congress, Beijing, China, 21-26 May, 2000
1Rheumatology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Insights
This rheumatology congress highlighted inflammatory cytokines and addressed atherosclerosis in rheumatic diseases. Discussions included regional conditions like Behcet's and Takayasu's diseases, alongside advancements in therapies.
Area of Science:
- Rheumatology
- Immunology
- Cardiovascular Science
Background:
- The congress convened global rheumatology experts, focusing on inflammatory cytokines and their role in rheumatic diseases.
- Key regional diseases such as Behcet's disease and Takayasu's disease were extensively discussed.
- Atherosclerosis in the context of rheumatic diseases was a significant topic.
Framework:
- The scientific program featured plenary lectures, symposia, workshops, and free paper sessions.
- Basic science research, particularly on inflammatory cytokines, was well-represented.
- Presentations covered a wide spectrum of rheumatological conditions and research areas.
Implementation:
- Symposia explored the latest pharmacological advances, including COX-2 inhibitors, leflunomide, and anti-tumour necrosis factor (TNF) therapy.
- Despite cost restrictions in the Asia Pacific League of Associations of Rheumatology (APLAR) region, recent drug developments were a focus.
- Management of spondyloarthritis and musculoskeletal infections in HIV-positive patients were also key discussion points.
Implications:
- The congress facilitated knowledge exchange on inflammatory cytokines and their impact on rheumatic diseases.
- It highlighted the need for accessible advanced therapies in regions like APLAR.
- The event underscored the interconnectedness of rheumatology, immunology, and cardiovascular health.
Abstract:
The Congress covered the broad field of rheumatology, with participants from China, the Asia Pacific League of Associations of Rheumatology (APLAR) region and the rest of the world. The programme consisted of a mix of plenary lectures, concurrent symposia, workshops, free paper sessions and poster presentations. Basic sciences were well represented, with the general theme of inflammatory cytokines being of particular interest. One plenary lecture and a number of other presentations addressed the problem of atherosclerosis and rheumatic diseases. Diseases prominent in the region, such as Behcet's disease and Takayasu's disease, were represented with large series. Other areas of interest were musculoskeletal infections in HIV-positive patients and the management of spondyloarthritis. Although the use of the most recently developed drugs is restricted in the APLAR region because of cost factors, there were symposia on the latest pharmacological advances such as COX-2 technology, leflunomide and anti-tumour necrosis factor (TNF) therapy.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
